The estimated Net Worth of Scott Shuda is at least 952 千$ dollars as of 14 May 2024. Mr. Shuda owns over 35,000 units of InfuSystem Inc stock worth over 809,436$ and over the last 10 years he sold INFU stock worth over 0$. In addition, he makes 142,817$ as Independent Chairman of the Board at InfuSystem Inc.
Scott has made over 10 trades of the InfuSystem Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 35,000 units of INFU stock worth 164,500$ on 14 May 2024.
The largest trade he's ever made was buying 72,479 units of InfuSystem Inc stock on 29 August 2018 worth over 229,034$. On average, Scott trades about 10,534 units every 74 days since 2014. As of 14 May 2024 he still owns at least 125,494 units of InfuSystem Inc stock.
You can see the complete history of Mr. Shuda stock trades at the bottom of the page.
Scott A. Shuda J.D. serves as Independent Chairman of the Board of the Company. Scott A. Shuda has been a member of the Company’s Board of Directors since September 7, 2016, and was elected Chairman of the Board effective December 19, 2018. Mr. Shuda is a Managing Director and Co-founder of Meridian OHC Partners, LP (“Meridian”) and BlueLine Partners, LLC (“BlueLine”), investment firms that focus on publicly listed technology and healthcare companies. Mr. Shuda served as a director of Iridex Corporation (NASDAQ: IRIX), a global leader in ophthalmic laser systems, from 2012 to 2017 where he was chairman of Iridex’s Compensation Committee and a member of the Nominating and Governance Committee. Mr. Shuda holds both a Juris Doctor degree and a Masters of Business administration degree from Georgetown University. Mr. Shuda has extensive experience with the medical devices industry. He brings more than 20 years of professional experience in law, technology and entrepreneurial endeavors in the industry, including transactions that range from initial public offerings and venture financings to mergers and acquisitions. Mr. Shuda serves as the Managing Director of TSV Investment Partners, LLC (“TSV”), which is the sole general partner of Meridian, the Company’s largest stockholder.
As the Independent Chairman of the Board of InfuSystem Inc, the total compensation of Scott Shuda at InfuSystem Inc is 142,817$. There are 6 executives at InfuSystem Inc getting paid more, with Richard A. DiIorio having the highest compensation of 1,062,576$.
Scott Shuda is 54, he's been the Independent Chairman of the Board of InfuSystem Inc since 2018. There are 5 older and 9 younger executives at InfuSystem Inc. The oldest executive at InfuSystem Holdings Inc is Gregg Lehman, 73, who is the Vice Chairman of the Board.
Scott's mailing address filed with the SEC is C/O INFUSYSTEM HOLDINGS, INC., 3851 WEST HAMLIN ROAD, ROCHESTER HILLS, MI, 48309.
Over the last 16 years, insiders at InfuSystem Inc have traded over 25,793,717$ worth of InfuSystem Inc stock and bought 3,095,076 units worth 8,235,942$ . The most active insiders traders include Investment Company, Inc. Awm、Point Partners Llcjay Jeffr...、Ryan J. Morris. On average, InfuSystem Inc executives and independent directors trade stock every 25 days with the average trade being worth of 365,992$. The most recent stock trade was executed by Richard Dilorio on 26 June 2024, trading 50,000 units of INFU stock currently worth 134,500$.
infusystem is a growing healthcare company that provides infusion pumps and related products and services for patients in the home, in oncology clinics, at ambulatory surgery centers, and other sites of care from five locations serving all 50 states and canada.
InfuSystem Inc executives and other stock owners filed with the SEC include: